Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhujun Cao

Showing results (21-30 of 61) with videos related to

Pageof 7
Sort By:
Hepatology International|September 9, 2024
Liver fibrosis is closely linked with metabolic-associated diseases in patients with autoimmune hepatitisKehui Liu, Mingyang Feng, Wanqing Chi, et al.
Scientific Reports|September 19, 2015
Circulating cell death biomarker: good candidates of prognostic indicator for patients with hepatitis B virus related acute-on-chronic liver failureZhujun Cao, Fengdi Li, Xiaogang Xiang, et al.
Frontiers of Medicine|January 2, 2024
Small-molecule anti-COVID-19 drugs and a focus on China's homegrown mindeudesivir (VV116)Qiuyu Cao, Yi Ding, Yu Xu, et al.
Canadian Journal of Gastroenterology & Hepatology|July 25, 2022
qHBsAg for the Identification of Liver Histological Abnormalities in HBeAg-Negative Chronic Hepatitis B Patients with Normal and Mildly Elevated ALT LevelsQinyi Gan, Yan Huang, Chuanwu Zhu, et al.
Frontiers in Physiology|July 14, 2020
Circulating Receptor-Interacting Protein Kinase 3 Are Increased in HBV Patients With Acute-on-Chronic Liver Failure and Are Associated With Clinical OutcomeLiwen Chen, Zhujun Cao, Lei Yan, et al.
Frontiers in Pharmacology|May 11, 2023
The safety concerns regarding immune checkpoint inhibitors in liver cancer patients rising mainly from CHBShike Lou, Zhujun Cao, Wanqing Chi, et al.
Cancer Medicine|March 10, 2020
Combination of inflammatory score/liver function and AFP improves the diagnostic accuracy of HBV-related hepatocellular carcinomaYezhou Ding, Kehui Liu, Yumin Xu, et al.
Frontiers in Physiology|January 11, 2020
Long Non-coding RNA NEAT1 Alleviates Acute-on-Chronic Liver Failure Through Blocking TRAF6 Mediated Inflammatory ResponseYumin Xu, Zhujun Cao, Yezhou Ding, et al.
Oncotarget|June 23, 2016
Randomized clinical trial: Nucleos(t)ide analogues improved survival of CHB-related HCC patients via reducing severity and progression of malignancyYun Wang, Xiaogang Xiang, Liwen Chen, et al.
Cell & Bioscience|February 28, 2018
Correlation between hepatic human males absent on the first (hMOF) and viral persistence in chronic hepatitis B patientsLiwen Chen, Chuanwu Zhu, Fengdi Li, et al.
Pageof 7

Showing results (21-30 of 61) with videos related to

Sort By:
Pageof 7
Hepatology International|September 9, 2024
Liver fibrosis is closely linked with metabolic-associated diseases in patients with autoimmune hepatitisKehui Liu, Mingyang Feng, Wanqing Chi, et al.
Scientific Reports|September 19, 2015
Circulating cell death biomarker: good candidates of prognostic indicator for patients with hepatitis B virus related acute-on-chronic liver failureZhujun Cao, Fengdi Li, Xiaogang Xiang, et al.
Frontiers of Medicine|January 2, 2024
Small-molecule anti-COVID-19 drugs and a focus on China's homegrown mindeudesivir (VV116)Qiuyu Cao, Yi Ding, Yu Xu, et al.
Canadian Journal of Gastroenterology & Hepatology|July 25, 2022
qHBsAg for the Identification of Liver Histological Abnormalities in HBeAg-Negative Chronic Hepatitis B Patients with Normal and Mildly Elevated ALT LevelsQinyi Gan, Yan Huang, Chuanwu Zhu, et al.
Frontiers in Physiology|July 14, 2020
Circulating Receptor-Interacting Protein Kinase 3 Are Increased in HBV Patients With Acute-on-Chronic Liver Failure and Are Associated With Clinical OutcomeLiwen Chen, Zhujun Cao, Lei Yan, et al.
Frontiers in Pharmacology|May 11, 2023
The safety concerns regarding immune checkpoint inhibitors in liver cancer patients rising mainly from CHBShike Lou, Zhujun Cao, Wanqing Chi, et al.
Cancer Medicine|March 10, 2020
Combination of inflammatory score/liver function and AFP improves the diagnostic accuracy of HBV-related hepatocellular carcinomaYezhou Ding, Kehui Liu, Yumin Xu, et al.
Frontiers in Physiology|January 11, 2020
Long Non-coding RNA NEAT1 Alleviates Acute-on-Chronic Liver Failure Through Blocking TRAF6 Mediated Inflammatory ResponseYumin Xu, Zhujun Cao, Yezhou Ding, et al.
Oncotarget|June 23, 2016
Randomized clinical trial: Nucleos(t)ide analogues improved survival of CHB-related HCC patients via reducing severity and progression of malignancyYun Wang, Xiaogang Xiang, Liwen Chen, et al.
Cell & Bioscience|February 28, 2018
Correlation between hepatic human males absent on the first (hMOF) and viral persistence in chronic hepatitis B patientsLiwen Chen, Chuanwu Zhu, Fengdi Li, et al.
Pageof 7